<DOC>
	<DOCNO>NCT01020188</DOCNO>
	<brief_summary>Paroxysmal nocturnal haemaoglobinuria ( PNH ) rare disease result breakdown red blood cell bone marrow failure . It associate increase risk blood clot . Until recently , treatment blood transfusion patient blood clot , blood thinner . A new treatment call eculizumab standard patient require regular blood transfusion . It work majority patient prevent breakdown red blood cell . This eliminate need blood transfusion reduce risk blood clot . It well understood patient PNH high risk blood clot . The investigator plan use specialised blood test assess stickiness blood start eculizumab treatment monthly start treatment . The investigator compare test standard test clot .</brief_summary>
	<brief_title>Study Global Coagulation Tests Patients With Paroxysmal Nocturnal Haemoglobinuria</brief_title>
	<detailed_description />
	<mesh_term>Hemoglobinuria , Paroxysmal</mesh_term>
	<mesh_term>Hemoglobinuria</mesh_term>
	<criteria>Presence PNH clone Longterm anticoagulation previous venous thrombosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>